Sign Up

Get the InvestingChannel
Free e-Letter Today

Learn More

Independent market opinion, analysis and ideas - delivered every business day

Premium market opinions, analysis, and ideas - delivered every business day

The Channel

  1. Michael Ballanger: The Golden ‘Moment...

    about 4 hours ago
    Silver Doctors
  2. Credibility Crisis: No One Believes...

    about 6 hours ago
    Silver Doctors
  3. The Crash Will Take Everybody Down w...

    about 6 hours ago
    Silver Doctors
  4. Wednesday: FOMC Announcement

    about 6 hours ago
    Calculated Risk
  5. Fund Manager: Can Western Central...

    about 7 hours ago
    Silver Doctors
  6. Fly Intel: After Hours Movers

    about 8 hours ago
    The Fly
  7. Will Libra impinge on monetary policy?

    about 9 hours ago
    TheMoneyIllusion
  8. How To Identify Mining Stocks Worth...

    about 9 hours ago
    Silver Doctors

Trade Idea of the Day Presented by: Baystreet.ca

Is Twitter Stock a Good Buy Today?

Twitter (NYSE:TWTR) stock was up 0.28% in mid-morning trading on June 17. Shares have climbed 25% in 2019 so far. The stock has slipped 5.6% over the past month. It took a beating after a top analyst lowered the price target in anticipation of slower revenue growth and rising costs. In the... Read More

Siemens Gas and Power to cut 2,700 jobs worldwide

Siemens informed its employee representatives about further planned measures for strengthening the productivity and competitiveness of Siemens' Gas and Power Operating Company for the long term. "Our new Gas and Power Operating Company setup has created synergies that better enable our company to deliver competitive performance in the midst of structural change in our industry. The planned measures will help us create more opportunity for growth and the security that comes from being a competitive player in the energy market," said Lisa Davis, member of the Managing Board of Siemens AG and CEO of Gas and Power. At its Capital Market Day on May 8, Siemens announced that, against the backdrop of a challenging market environment, GP will - in addition...

Fly Intel: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Bank of America (BAC) upgraded to Outperform from Market Perform at BMO Capital with analyst James Fotheringham expecting upward consensus estimates revisions and a "multiple re-rating" to drive 34% total return in the shares. 2. SunPower (SPWR), SunRun (RUN) upgraded to Buy from Neutral as SolarEdge (SEDG) upgraded to Neutral from Sell at Goldman Sachs with analyst Brian Lee anticipating "volume tailwinds" in the second half of 2019 given the recent signs of strength in the sector's financing environment. 3. CNH Industrial (CNHI) upgraded to Hold from Sell at Deutsche Bank with analyst Chad Dillard saying he's turning positive on North America large agriculture. 4. U.S. Cellular (USM)...

Stocks Progress in Lead-up to Fed Meeting

Stocks rose slightly on Monday as investors looked ahead to a crucial Federal Reserve meeting this week. The Dow Jones Industrial Average retained 57.9 to pause for lunch at 26,147.51. The S&P 500 eked ahead 4.64 points at 2,891.58 The NASDAQ Composite 48.24 points to 7,844.90, as tech shares gained. Facebook acquired 2.6%, and Netflix climbed 3.1%, while Amazon advanced 1%. Alphabet and Apple both traded nearly 1% higher. Disney shares slipped 0.6% after an analyst at Imperial Capital downgraded the stock to in-line from outperform, citing a “record ” valuation. Shares of auction house Sotheby’s shot up nearly 60% on news it will be bought for $3.7 billion by BidFair USA. Array BioPharma shares also surged nearly 60% after the company was acquired by Pfizer for $10.6 billion. Equities posted slight gains...

Pfizer to Buy Array for $10.6B

Pfizer (NYSE: PFE) said on Monday it would acquire Array Biopharma (NASDAQ: ARRY) for $10.64 billion in cash, giving it access to the target’s approved drugs for skin cancer and the targeted cancer medicines in its pipeline. The offer of $48 per Array share represents a premium of about 62% to the stock’s close on Friday. Array’s shares hiked $17.01, 57.5%, to $46.60 in early Monday trade. Array's portfolio includes the approved combined use of BRAFTOVI® (encorafenib) and MEKTOVI® (binimetinib) for the treatment of BRAFV600E or BRAFV600K mutant unresectable or metastatic melanoma. The combination therapy has significant potential for long-term growth via expansion into additional areas of unmet need and is currently being investigated in over 30 clinical trials across several solid...

Apollo Wins FDA Nod

Apollo Endosurgery Inc (NASDAQ:APEN) disclosed that it has received FDA approval for its labeling updates for the ORBERA Intragastric Balloon System. The Austin, Texas-based Apollo, which boasts a status as a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced the nod Thursday. The goal of the labeling updates is to improve patient safety and these will take effect immediately. The labeling updates improve patient safety by providing further definition and guidance on the appropriate use of the ORBERA® Intragastric Balloon System and patient selection. The most notable safety labeling updates included: Clarification to contraindications. These changes clarified that the previous "hepatic insufficiency or cirrhosis" contraindication related to patients with acute...

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Transocean (RIG) downgraded to Neutral from Buy at Citi with analyst Scott Gruber saying his organic cash burn analysis implies the drillers will burn cash until "at least" 2021. 2. CommScope (COMM) downgraded to Outperform from Strong Buy at Raymond James with analyst Simon Leopold saying he is concerned that performance of the acquired ARRIS business will be worse than expected. 3. Spirit AeroSystems (SPR), Astronics (ATRO), and Barnes Group (B) were downgraded to Sell from Hold at SunTrust while Woodward (WWD) and Ducommun (DCO) were downgraded to Hold from Buy. 4. Melinta Therapeutics (MLNT) downgraded to Underweight from Neutral at JPMorgan with...

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Cooper-Standard (CPS) downgraded to Sell from Neutral at Goldman Sachs with analyst David Tamberrino saying the company's production-levered content is "not differentiated enough to fight the cycle" and its exposure to manufacturers, particularly to Ford (F), is unfavorable. 2. Marathon Oil (MRO) downgraded to Neutral from Overweight at Atlantic Equities with analyst Barry Maccarthy citing crude oil price concerns for the downgrade. 3. CyrusOne (CONE) downgraded to Neutral from Buy at UBS with analyst John Hodulik saying he expects the company to benefit from long-term secular trends in the data center industry but has growing concerns that near-term hyperscale demand will remain "subdued" longer than expected.Union Pacific (UNP) downgraded...

Fly Intel: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Delphi Technologies (DLPH) upgraded to Buy from Neutral at Goldman Sachs with analyst David Tamberrino saying new CEO Rick Dauch's more operationally focused initiatives should drive "idiosyncratic" margin and free cash flow expansion into 2020. 2. Williams-Sonoma (WSM) upgraded to Accumulate from Hold at Gordon Haskett with analyst Chuck Grom saying following the meetings, and based on more upbeat than expected results from peer RH (RH), he has a higher degree of confidence about both the company's near-term results and its long-term options. 3. Concert Pharmaceuticals (CNCE) upgraded to Buy from Neutral at Janney Montgomery Scott with analyst Esther Hong saying CTP-692...

Recent Tweets @InvestChannel

Follow Us on Twitter